Engineered Hybrid Nanovesicles Combining Macrophage Membranes and Artificial Lipids for Abdominal Aortic Aneurysm Therapy
Weiyao Chen, Jiling Zhao, Jiamin Xu, Heng Wu, Zhongnan Xia, Jie Liu, Shilong Sun, Yuhua Lei, Hongbo Chen, Jiaqi Yu, Jiaxin Hu · 2025
Read Engineered Hybrid Nanovesicles Combining Macrophage Membranes and Artificial Lipids for Abdominal Aortic Aneurysm Therapy by Weiyao Chen, Jiling Zhao, Jiamin Xu, Heng Wu, Zhongnan Xia, Jie Liu, Shilong Sun, Yuhua Lei, Hongbo Chen, Jiaqi Yu, Jiaxin Hu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12743546.txt.
Description
Weiyao Chen and a team of co-authors build a targeted carrier for a drug against aortic swelling in a 2025 paper. A swollen belly aorta can burst and kill, yet no drug is approved to treat it. A plant compound protects vessel wall cells but harms the whole body at useful doses, so the team wrap it in tiny bubbles.
The bubbles blend membranes from immune cells with made lipids, which helps them find stressed vessel cells and release the drug slowly. In mice prone to this swelling, the carrier cut new cases, shrank peak vessel width, and blocked fatal bursts. Liver and kidney harm also fell versus the free drug.
Catalog record
| CREATOR | Weiyao Chen, Jiling Zhao, Jiamin Xu, Heng Wu, Zhongnan Xia, Jie Liu, Shilong Sun, Yuhua Lei, Hongbo Chen, Jiaqi Yu, Jiaxin Hu |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |